Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Whole-body positron emission tomography can reassure cervical cancer patients

Whole-body PET (positron emission tomography) scans done three months after completion of cervical cancer therapy can ensure that patients are disease-free or warn that further interventions are needed, according to a study at Washington University School of Medicine in St. Louis.

21 Nov 2007

Dyslexia expert Dr. Bruce McCandliss awarded Presidential honor

Dr. Bruce McCandliss, a psychologist at the Sackler Institute for Developmental Psychobiology and associate professor of psychology in psychiatry at Weill Cornell Medical College, has received a commendation by the President of the United States in the form of a Presidential Early Career Award for Scientists and Engineers (PECASE).

20 Nov 2007

New HPV vaccine 'nine-valent' under study

A new vaccine against nine of the most harmful strains of human papillomavirus is under study at the Medical College of Georgia.

19 Nov 2007

NewYork-Presbyterian/Weill Cornell opens new section of general surgery called Gastrointestinal Metabolic Surgery

Opening the doors to one of the first academic medical program dedicated to surgical treatment of type 2 diabetes, NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created a new section of General Surgery called Gastrointestinal Metabolic Surgery.

19 Nov 2007

Hidden epidemic of sexually transmitted diseases in the U.S.

Health experts in the United States say the country has achieved an all-time record for a sexually transmitted disease.

14 Nov 2007

Big British problem with booze

A newly-formed group in Britain called the 'Alcohol Health Alliance' is calling for better alcohol prevention and treatment strategies to deal with the escalating alcohol problem.

14 Nov 2007

Most UK citizens susceptible to hep B infection

The failure of the UK to introduce universal hepatitis B immunisation means that most UK citizens are susceptible to infection, warns an infectious diseases expert in this week's BMJ.

13 Nov 2007

Review of controversy surrounding the human papillomavirus (HPV) vaccine

In an article appearing in the current issue of Clinical Pharmacology & Therapeutics, experts from the University of Pennsylvania Center for Bioethics and Johns Hopkins Berman Institute of Bioethics review the controversy surrounding the human papillomavirus (HPV) vaccine debate, and its effects on ethical and public health issues.

2 Nov 2007

How one virus mimicks a normal cellular protein to replicate successfully

Both viruses and cancers subvert the growth-control machinery in a cell to serve their own needs.

1 Nov 2007

Significant improvement over current test for human papillomavirus

Iowa State University researchers have developed a technology that detects a single molecule of the virus associated with cervical cancer in women.

31 Oct 2007

Cancers successfully treated by targeting the viruses that cause them

Researchers at the Albert Einstein College of Medicine of Yeshiva University have shown for the first time that cancers can be successfully treated by targeting the viruses that cause them.

31 Oct 2007

Women who have precancerous lesions removed have increased risk of developing cervical, vaginal cancer for at least 25 years

Women who have precancerous lesions removed from their cervix are at an increased risk of developing cervical or vaginal cancer during the 25 years after the procedure, according to a study published on Friday in BMJ, Reuters reports.

29 Oct 2007

Twice the risk of cervical cancer despite operation

Women who have had severe cell changes in the cervix and who have been operated on for them run twice the risk of developing cancer later in life, compared with other women.

28 Oct 2007

Women still face cancer risk 25 years after treatment

Women are still at risk of developing invasive cancer of the cervix or vagina 25 years after being treated for pre-cancerous lesions, according to a study published today on bmj.com.

25 Oct 2007

Canadians would welcome HPV vaccine if it were free

Canadians would welcome a vaccine against the human papillomavirus (HPV) if it were introduced at no charge, a Quebec, Canada survey suggests.

24 Oct 2007

Alcoholism in the family linked to greater sweet preferences among women

More than 250 million women worldwide smoke tobacco. Compared to men, women have a greater risk of smoking-related diseases, and also have more difficulty quitting. A new study, the first of its kind, has found that cigarette smoking and having a family history of alcoholism have different effects on sweet-taste perception and food cravings.

24 Oct 2007

HPV test beats Pap in detecting cervical cancer

A new study led by McGill University researchers shows that the human papillomavirus (HPV) screening test is far more accurate than the traditional Pap test in detecting cervical cancer.

18 Oct 2007

HiFi DNA Tech files lawsuit against FDA

A lawsuit was filed Oct. 12 in U.S. District Court against the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) related to reclassification of HPV DNA tests from class III to class II devices. The inaction by both agencies hinders introduction of new and affordable HPV testing to improve women’s health care.

15 Oct 2007

Trial results of lovaxin C in advanced cervical cancer patients

A first-in-man trial of a live Listeria vaccine was reported by Advaxis Inc. The Phase I/II trial was testing Lovaxin C in advanced cervical cancer patients.

10 Oct 2007

Improvements in cancer survival in Northern Ireland

There have been improvements in cancer survival in Northern Ireland between 1993 and 2004, according to a new report from the Northern Ireland Cancer Registry (NICR), launched at Queen’s today.

4 Oct 2007